The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Company Fundraising - PulsiV Solar Ltd

27 Oct 2015 07:00

RNS Number : 4849D
Frontier IP Group plc
27 October 2015
 

 

 

AIM: FIPP

27 October 2015

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Uplift in Frontier IP's portfolio valuation following completion of PulsiV fundraising

 

 

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce a significant uplift in the value of its portfolio company PulsiV Solar Ltd ("PulsiV Solar"), following the successful completion of PulsiV Solar's first fundraising.

 

PulsiV Solar has received commitments totalling £0.5 million which will result in Frontier IP's holding in PulsiV Solar being revalued to show an uplift of over £0.87 million. The increase will be partially recognised in Frontier IP's financial statements for the year ended 30 June 2015, with the balance expected to be recognised in the Group's interim statements for the six months ending 31 December 2015. The fundraise values PulsiV Solar at £5 million with Frontier IP retaining an 18.9% holding in the issued share capital.

 

PulsiV Solar, which spun-out from Plymouth University, has developed new technology which significantly improves the energy efficiency of photovoltaic solar panels. It does this by maximising the energy generated by the system's inverters, which convert the energy harvested for supply to the grid. The global solar inverter market is forecast to be valued at approximately $7 billion in 2015, according to GTM Research. Results from PulsiV Solar's first prototype show a typical increase of up to 30% in energy generation when compared with conventional inverter technology. The technology can be integrated into new systems or retrofitted to existing solar panels.

 

This fundraising will allow PulsiV Solar to accelerate product development, enabling further prototyping and testing in preparation for the initial production of micro-inverters containing its technologies.

 

Dr. Mohamed Zaki Ahmed, Chief Technology Officer of PulsiV Solar, said:

 

"Frontier IP has played a key role in enabling us to successfully close our first fundraising. Frontier is also leveraging its relationships in the energy sector to open up further opportunities as we look to realise the commercial potential of PulsiV Solar's technology. We are delighted to have Frontier IP's active involvement in the commercialisation process and look forward to the next stage in our growth."

 

Neil Crabb, Chief Executive of Frontier IP, said:

 

"The technology being developed by our portfolio company PulsiV Solar, has the potential to drive significant gains in the energy efficiency of solar panels and other photovoltaic systems. We have been delighted to assist with the Company's first funding round and will continue to deploy our energy sector experience to take this ground-breaking technology to market."

 

Enquiries

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

T: 020 7894 7000

David Foreman, Catherine Leftley, Corporate Finance

David Banks, Corporate Broking

Peterhouse Corporate Finance Limited

(Joint Broker)

T: 020 7469 0935

Lucy Williams

Kreab

T: 020 7074 1800

Robert Speed, Matthew Jervois

 

 

Notes to Editor:

 

About Frontier IP Group plc

www.frontierip.co.uk.

 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses. Frontier IP currently has seventeen companies in its portfolio, which exploit IP from a range of institutions.

About PulsiV Solar Limited

 

PulsiV Solar was set up by Dr. Mohamed Zaki Ahmed, Plymouth University and Frontier IP Group PLC and develops a novel inverter technology to improve power take-off from photovoltaic solar panels. PulsiV Solar's technology aims to maximise the energy generated by solar inverters and is a potentially disruptive technology, capable of retro-fit. The PulsiV Solar team is based at Plymouth University, with key strategic and support functions being provided by Frontier IP Group plc.

Dr Mohammed Zaki Ahmed, Chief Technology Officer of PulsiV Solar, has led the development of this breakthrough technology and has a successful track record with other innovations, including train collision avoidance systems, which are now widely adopted across the world.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDQLFLEBFXFBQ
Date   Source Headline
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.